Murat Tuncel
Overview
Explore the profile of Murat Tuncel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
284
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
von Eyben R, Hoffmann M, Soydal C, Virgolini I, Tuncel M, Gauthe M, et al.
Biomedicines
. 2023 Sep;
11(9).
PMID: 37760775
Background: A biochemical recurrence (BCR) risk model was created based on pretest prostate specific antigen (PSA) and groupings by restaging prostate specific membrane antigen (PSMA) PET/CT. Methods: A cohort of...
12.
Petranovic Ovcaricek P, Campenni A, de Keizer B, Deandreis D, Kreissl M, Vrachimis A, et al.
Cancers (Basel)
. 2023 Sep;
15(17).
PMID: 37686566
Differentiated thyroid cancer (DTC) is the most common subtype of thyroid cancer and has an excellent overall prognosis. However, metastatic DTC in certain cases may have a poor prognosis as...
13.
Soydas-Turan B, Tuncel M
Clin Nucl Med
. 2023 Sep;
48(10):879-880.
PMID: 37682603
Lymphoscintigraphy is a safe, minimally invasive, and well-established imaging modality for evaluating lymphatic drainage in patients with suspected lymphedema. We report a case of an 8-year-old girl with lymphangioma circumscriptum...
14.
Kupik O, Tuncel M, Ozgen Kiratli P, Akpinar M, Altundag K, Basaran Demirkazik F, et al.
Mol Imaging Radionucl Ther
. 2023 Jun;
32(2):94-102.
PMID: 37337702
Objectives: This prospective study was planned to compare the predictive value of dynamic F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in locally advanced breast cancer patients (LABC) receiving neoadjuvant chemotherapy...
15.
Telli T, Tuncel M, Karabulut E, Aksoy S, Erman M, Akdogan B, et al.
Prostate
. 2023 Mar;
83(8):792-800.
PMID: 36919876
Background: Metastatic castration-resistant prostate cancer (mCRPC) is characterized by heterogeneity among patients as well as therapy responses due to diverse genetic, epigenetic differences, and resistance mechanisms. At this stage of...
16.
von Eyben R, Kapp D, Hoffmann M, Soydal C, Uprimny C, Virgolini I, et al.
Cancers (Basel)
. 2023 Feb;
15(4).
PMID: 36831697
In the original publication [...].
17.
von Eyben R, Kapp D, Hoffmann M, Soydal C, Uprimny C, Virgolini I, et al.
Cancers (Basel)
. 2022 Nov;
14(21).
PMID: 36358880
An individual patient meta-analysis followed 1216 patients with PSA-only recurrence (biochemical recurrence, BCR) restaged with [68Ga]Ga-PSMA-11 PET/CT before the salvage treatment for median 3.5 years and analyzed the overall survival...
18.
Arslan D, Ardic F, Gultekin-Zaim O, Tuncel M, Kertmen N, Gocmen R, et al.
Neurologia (Engl Ed)
. 2022 Sep;
38(6):443-446.
PMID: 36049648
No abstract available.
19.
Petranovic Ovcaricek P, Kreissl M, Campenni A, de Keizer B, Tuncel M, Vrachimis A, et al.
Eur J Nucl Med Mol Imaging
. 2022 Aug;
49(12):3959-3963.
PMID: 35947178
No abstract available.
20.
Schenke S, Campenni A, Tuncel M, Bottoni G, Sager S, Bogovic Crncic T, et al.
Diagnostics (Basel)
. 2022 Jun;
12(6).
PMID: 35741167
Tc-MIBI (MIBI) imaging is able to exclude malignancy of hypofunctioning thyroid nodules (TNs) with high probability but false positive results are frequent due to low specificity. Therefore, pre-test selection of...